XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
CAH Cardinal Health
- 126.210
- -0.570-0.45%
Close Feb 14 16:00 ET
- 128.010
- +1.800+1.43%
Post 20:01 ET
30.49BMarket Cap23.50P/E (TTM)
127.900High126.160Low1.62MVolume127.000Open126.780Pre Close205.67MTurnover0.67%Turnover Ratio36.58P/E (Static)241.57MShares132.84052wk High-10.19P/B30.33BFloat Cap92.34552wk Low2.02Dividend TTM240.31MShs Float132.840Historical High1.60%Div YieldTTM1.37%Amplitude14.473Historical Low126.930Avg Price1Lot Size
Cardinal Health Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -133.93%-400M | -411.93%-1.65B | 32.28%3.76B | 140.67%2.08B | -101.62%-22M | 97.49%1.18B | 2,195.65%528M | -10.43%2.84B | -71.66%863M | 424.82%1.36B |
| Net income from continuing operations | 8.67%401M | 3,890.91%417M | 157.70%853M | 7,700.00%234M | -24.78%261M | 383.85%369M | -109.91%-11M | 135.33%331M | -97.73%3M | 124.96%347M |
| Depreciation and amortization | 9.71%192M | 5.81%182M | 2.60%710M | 5.68%186M | 1.14%177M | 2.94%175M | 0.58%172M | 0.00%692M | -1.68%176M | -3.31%175M |
| Deferred tax | ---- | ---- | -160.00%-104M | ---- | ---- | ---- | ---- | -385.71%-40M | ---- | ---- |
| Change In working capital | -274.92%-1.04B | -981.13%-2.29B | 230.42%1.51B | 394.87%1.74B | -178.28%-609M | 385.58%594M | 54.31%-212M | -62.23%457M | -85.44%351M | 184.98%778M |
| -Change in receivables | -0.56%-541M | 396.55%288M | -4.84%-996M | -66.82%-734M | -46.70%218M | -30.90%-538M | 111.42%58M | 32.38%-950M | -107.55%-440M | 147.34%409M |
| -Change in inventory | 6.32%-1.29B | 36.81%-678M | 370.63%1.12B | 314.33%2.49B | 70.84%1.08B | 0.22%-1.38B | -306.44%-1.07B | 65.78%-412M | 312.77%600M | 212.48%631M |
| -Change in payables and accrued expense | -68.46%791M | -336.86%-1.9B | -23.53%1.39B | -107.85%-15M | -627.10%-1.91B | 58.53%2.51B | 160.71%803M | -52.37%1.82B | -93.42%191M | -115.43%-262M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -133.93%-400M | -411.93%-1.65B | 32.28%3.76B | 140.67%2.08B | -101.62%-22M | 97.49%1.18B | 2,195.65%528M | -10.43%2.84B | -71.66%863M | 424.82%1.36B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -829.52%-976M | -39.68%-88M | -307.27%-1.85B | 180.58%166M | -1,929.67%-1.85B | -20.69%-105M | 10.00%-63M | -180.07%-454M | -0.98%-206M | -106.82%-91M |
| Net PPE purchase and sale | 12.39%-99M | 1.10%-90M | -6.40%-499M | 7.73%-191M | 4.59%-104M | -32.94%-113M | -33.82%-91M | -31.74%-469M | -43.75%-207M | 89.20%-109M |
| Net business purchase and sale | -12,055.56%-1.08B | --2M | -11,710.00%-1.18B | --2M | -11,820.00%-1.19B | --9M | --0 | -101.11%-10M | --0 | -101.08%-10M |
| Net investment purchase and sale | 20,000.00%199M | --0 | -776.00%-169M | 35,400.00%355M | -2,067.86%-551M | 50.00%-1M | 1,500.00%28M | 13.64%25M | 102.63%1M | -33.33%28M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -829.52%-976M | -39.68%-88M | -307.27%-1.85B | 180.58%166M | -1,929.67%-1.85B | -20.69%-105M | 10.00%-63M | -180.07%-454M | -0.98%-206M | -106.82%-91M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 760.34%2.33B | 18.92%-540M | 72.24%-847M | -45.10%-859M | 210.39%1.03B | 2.49%-353M | 42.73%-666M | -23.87%-3.05B | -42.65%-592M | -174.71%-934M |
| Net issuance payments of debt | 30,787.50%2.46B | -28.57%-9M | 161.49%356M | -9,400.00%-760M | 302.69%1.13B | -33.33%-8M | 0.00%-7M | 34.58%-579M | 97.22%-8M | -11,060.00%-558M |
| Net common stock issuance | 94.00%-15M | 25.00%-375M | 62.50%-750M | --0 | --0 | 0.00%-250M | 50.00%-500M | -100.00%-2B | ---500M | -25.00%-250M |
| Cash dividends paid | 1.61%-122M | 2.29%-128M | 4.95%-499M | 3.17%-122M | 4.69%-122M | 3.88%-124M | 7.75%-131M | 6.08%-525M | 5.97%-126M | 5.88%-128M |
| Net other financing activities | -55.17%13M | 0.00%-28M | -13.21%46M | -45.24%23M | 1,000.00%22M | 26.09%29M | -100.00%-28M | 378.95%53M | 500.00%42M | 100.00%2M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 760.34%2.33B | 18.92%-540M | 72.24%-847M | -45.10%-859M | 210.39%1.03B | 2.49%-353M | 42.73%-666M | -23.87%-3.05B | -42.65%-592M | -174.71%-934M |
| Net cash flow | ||||||||||
| Beginning cash position | -25.92%2.87B | 25.93%5.13B | -14.10%4.08B | -6.82%3.72B | 25.81%4.6B | 10.82%3.87B | -13.59%4.08B | 40.30%4.75B | 69.35%3.99B | 15.60%3.65B |
| Current changes in cash | 32.45%955M | -1,031.84%-2.28B | 261.27%1.07B | 2,029.23%1.38B | -349.40%-838M | 387.16%721M | 83.39%-201M | -151.68%-661M | -97.32%65M | 141.84%336M |
| Effect of exchange rate changes | -300.00%-12M | 280.00%9M | -12.50%-9M | 71.43%-2M | ---8M | -57.14%6M | 66.67%-5M | 68.00%-8M | 41.67%-7M | --0 |
| End cash Position | -17.12%3.81B | -25.92%2.87B | 25.93%5.13B | 25.93%5.13B | -6.82%3.72B | 25.81%4.6B | 10.82%3.87B | -14.10%4.08B | -14.10%4.08B | 69.35%3.99B |
| Free cash flow | -146.85%-499M | -498.39%-1.74B | 37.58%3.25B | 191.64%1.88B | -110.70%-134M | 108.01%1.07B | 1,027.66%436M | -15.24%2.36B | -77.58%646M | 349.90%1.25B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Trending Stocks
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1
Popular on moomoo
Feb 13 17:34
China's asset revaluation sparks debate: What are mooers buying?